We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hutchmed (china) Limited | LSE:HCM | London | Ordinary Share | KYG4672N1198 | ORD USD0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
14.00 | 5.07% | 290.00 | 290.00 | 292.00 | 295.00 | 275.00 | 275.00 | 262,868 | 16:29:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 838M | 100.78M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/3/2014 15:32 | "he is predicting further significant rises in other stocks, such as the new top holding in the fund, Hutchison China Meditech, which he thinks is "absurdly undervalued"." "The manager also tipped Hutchison China Meditech now Mr Slater's top holding at 7.3 per cent whose share price he said was "completely wrong" and failed to reflect the company's potential." | protean | |
18/2/2014 22:53 | Ali30 - i hold avap too :-) | gucci | |
18/2/2014 22:51 | A new holding was also taken in Utilitywise i found this on the utw thread Praipus | gucci | |
18/2/2014 17:36 | Share_shark it's a beautiful thing :-) Gucci I cant find any connection between the Slaters and UTW please can you elaborate? Here's the ones I know about so far: | praipus | |
18/2/2014 17:15 | So you are all Slaters together then............with the exception of myself ?. :-( | share_shark | |
18/2/2014 17:07 | One of those shares I held a while ago and nothing happened so sold them, now good progress - congrats you holders, wish i hadnt sold! I hold AVAP as well, good little co that I will not sell out of - learnt my lesson with HCM | ayl30 | |
18/2/2014 14:14 | Hi, I follow a few of the slater pics as well notably Avation AVAP also worth a look. | rabiddog | |
18/2/2014 13:53 | hello SS. looking forward to holding these to £10.00 hopefully in a couple of years if not before! i hold quite a few of Mark Slater shares, one of the latter ones being UTW worth a look | gucci | |
18/2/2014 10:26 | $HCM Hutch china meditech analysts meeting. Very positive tone: big big year for drug trials. Co has delivered so far: expect more success | protean | |
18/2/2014 08:56 | Thank you Praipus for that information and will take a look. No I do not have any of the Slater shares. Yes gucci and hi again, a great set of results !. Or should I say fantastic. | share_shark | |
18/2/2014 08:07 | fantastic set of results!!! | gucci | |
13/2/2014 12:11 | Hi share_shark, Lot of respect for Slater Invesments choice of holdings and the books written by Jim Slater so I track their known holdings through RNS on the WAM thread and dedciate a post to the charts of their holdings. Do you hold any other stock where the Slaters managed funds are on the register? | praipus | |
13/2/2014 08:19 | RNS. Holdings. | share_shark | |
05/2/2014 09:04 | heading back up, i'm in again | gucci | |
19/11/2013 11:03 | possibe 500p ? any chartists around? | gucci | |
01/11/2013 09:42 | will look for 550p to get back in | gucci | |
01/11/2013 07:53 | sold out yesterday | gucci | |
21/10/2013 09:32 | Citywire: "UBS has upped its target price for Hutchison China MediTech (HCM.L), which it rates as a 'buy', having been encouraged about the quality of its drugs pipeline." hxxp://is.gd/ml29KN | blippy2 | |
09/10/2013 09:17 | breaking out ! | gucci | |
09/10/2013 07:10 | RNS ..another ! Candidate Nomination of Novel Small-Molecule Therapy in Inflammation Triggers Milestone Payment From Janssen Pharmaceuticals, Inc. London: Wednesday, 9 October 2013: Chi-Med today announces that Hutchison MediPharma Limited ("HMP"), its majority owned R&D company, is set to receive a milestone payment of US$6 million from Janssen Pharmaceuticals, Inc. ("Janssen"), pursuant to the global strategic alliance (the "Agreement") to develop novel small-molecule therapeutics against a target in the area of inflammation/immunol | share_shark | |
09/10/2013 07:04 | Rns, Excellent news. | share_shark | |
18/9/2013 15:31 | no events in the calendar now for a while but I wouldn't be surprised to see an update on re: the development of HMPL-004 trials | daveycaferacer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions